Rankings
▼
Calendar
BDSX Q1 2024 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena
BDSX
Biodesix, Inc.
$151M
Q1 2024 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$15M
+63.6% YoY
Gross Profit
$12M
78.6% margin
Operating Income
-$11M
-74.4% margin
Net Income
-$14M
-91.9% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
+1.0%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$16M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$87M
Total Liabilities
$93M
Stockholders' Equity
-$6M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15M
$9M
+63.6%
Gross Profit
$12M
$6M
+97.8%
Operating Income
-$11M
-$16M
+32.7%
Net Income
-$14M
-$19M
+27.2%
Revenue Segments
Diagnostic Tests
$14M
100%
← FY 2024
All Quarters
Q2 2024 →